HERRIOT PHARMA UK TOPCO LIMITED

Active London

Activities of other holding companies n.e.c.

685 employees website.com
Activities of other holding companies n.e.c.
H

HERRIOT PHARMA UK TOPCO LIMITED

Activities of other holding companies n.e.c.

Founded 1 Mar 2024 Active London, United Kingdom 685 employees website.com
Activities of other holding companies n.e.c.
Accounts Submitted 20 Jan 2026 Next due 31 Jan 2027 9 months remaining
Confirmation Submitted 2 Apr 2026 Next due 14 Mar 2027 10 months remaining
Net assets £-28M
Total assets £252M
Total Liabilities £280M
Charges None No charges registered

Contact & Details

Contact

Registered Address

30 Broadwick Street London W1F 8JB United Kingdom

Full company profile for HERRIOT PHARMA UK TOPCO LIMITED (15535188), an active company based in London, United Kingdom. Incorporated 1 Mar 2024. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Balance Sheet & P&L (2025–2025)

Cash in Bank

£15.07M

Net Assets

-£27.92M

Total Liabilities

£279.57M

Turnover

£189.85M

Employees

685

Debt Ratio

111%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

14 Allotments 179,806,284 Shares £40504081.83m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 Oct 2025568,032€568k€1
13 Oct 20251€0.64€0.64
13 Oct 2025343,685€3k€0.01
13 Oct 20257,100,000€71k€0.01
6 Jan 2025559,117€559k€559k

Officers

Officers

3 active
Status
Gunton, James MichaelDirectorBritishUnited Kingdom431 Mar 2024Active
Hoffman, JeanDirectorAmericanUnited States6823 May 2025Active
Mulveen, Aubrey John FrancisDirectorIrishIreland573 Apr 2024Active

Shareholders

Shareholders (10)

Exponent Private Equity Co-investment Gp Llp
40.1%
92,096,814
Exponent Private Equity Partners Gp V Lp
20.2%
46,411,093

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased
Active
Notified 3 Apr 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Notified 3 Apr 2024
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors
Ceased

Group Structure

Group Structure

HERRIOT PHARMA UK TOPCO LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Apr 2026CapitalAllotment of shares (EUR 2,378,037.77) on 2026-04-16
2 Apr 2026Confirmation StatementConfirmation statement made on 2026-02-28 with updates
20 Jan 2026AccountsAnnual accounts made up to 2025-04-30
7 Nov 2025CapitalCapital Name Of Class Of Shares
7 Nov 2025CapitalCapital Variation Of Rights Attached To Shares
21 Apr 2026 Capital

Allotment of shares (EUR 2,378,037.77) on 2026-04-16

2 Apr 2026 Confirmation Statement

Confirmation statement made on 2026-02-28 with updates

20 Jan 2026 Accounts

Annual accounts made up to 2025-04-30

7 Nov 2025 Capital

Capital Name Of Class Of Shares

7 Nov 2025 Capital

Capital Variation Of Rights Attached To Shares

Recent Activity

Latest Activity

Allotment of shares (EUR 2,378,037.77) on 2026-04-16

4 days ago on 21 Apr 2026

Confirmation statement made on 2026-02-28 with updates

3 weeks ago on 2 Apr 2026

Annual accounts made up to 2025-04-30

3 months ago on 20 Jan 2026

Capital Name Of Class Of Shares

5 months ago on 7 Nov 2025

Capital Variation Of Rights Attached To Shares

5 months ago on 7 Nov 2025